MediPharm Labs Signs The Supreme Cannabis Company for Cannabis Concentrate Program

Nov 14, 2018

MediPharm Labs Corp. Receives Sales Licence from Health Canada

Nov 12, 2018

MediPharm Labs Adds to Bench Strength with Strategic Hires

Nov 8, 2018

MediPharm Labs Corp. Completes Major Extraction Milestone

Nov 7, 2018

MediPharm Labs Corp. Announces Grant of Stock Options

Oct 24, 2018

MediPharm Labs Corp. Bolsters Leadership & Operational Expertise to Further Accelerate Growth

Oct 19, 2018

MediPharm Labs Corp. and Emerald Health Therapeutics, Inc. Sign Cannabis Concentrate Program Agreement

Oct 10, 2018

MediPharm Labs Corp. (TSXV: LABS) (Formerly POCML 4 Inc.) Provides Corporate Update Upon Commencement of Trading on the TSXV

Oct 4, 2018

MediPharm Labs Corp. (formerly POCML 4 Inc.) Announces Closing of Business Combination With MediPharm Labs Inc. and Anticipated Trading Date of October 4, 2018

Oct 2, 2018

POCML 4 Inc. Files Filing Statement in Connection With Proposed Qualifying Transaction With MediPharm Labs Inc.; Expects to Commence Trading on TSXV Under the Ticker Symbol “LABS” on or About October 3, 2018

Sep 25, 2018